e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Modulating the immune system in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways
Anna James (Stockholm, Sweden), Martijn Manson, Anna James, Jesper Säfholm, Mamdoh Al-Ameri, Per Bergman, Ann-Charlotte Orre, Sven-Erik Dahlén, Mikael Adner
Source:
International Congress 2015 – Modulating the immune system in COPD and asthma
Session:
Modulating the immune system in COPD and asthma
Session type:
Poster Discussion
Number:
3603
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anna James (Stockholm, Sweden), Martijn Manson, Anna James, Jesper Säfholm, Mamdoh Al-Ameri, Per Bergman, Ann-Charlotte Orre, Sven-Erik Dahlén, Mikael Adner. IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways. Eur Respir J 2015; 46: Suppl. 59, 3603
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle
Source: Eur Respir J 2004; 24 : 559-567
Year: 2004
Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Mechanisms of bronchial hyperresponsiveness in a clinical setting – putative role of smooth muscle
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Contribution of bronchial smooth muscle to inflammation
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Treating asthma means treating airway smooth muscle cells
Source: Eur Respir J 2008; 32: 265-274
Year: 2008
Corticosteroid insensitivity in airway smooth muscle cells from severe asthma is dependent on stimulus and cytokine product
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Physiological responses of the airway wall and lung in hyperresponsive pigs
Source: Eur Respir J 2001; 18: 935-941
Year: 2001
Low-level laser therapy effect on the bronchial hyperresponsiveness and the chronic allergy airway inflammation is driven to RhoA signaling and STAT-6
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Hypoxia exerts dualistic effects on inflammatory and proliferative responses of healthy and asthmatic primary human bronchial smooth muscle cells
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Distribution of increased airway smooth muscle thickness and airway inflammation in asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Glucagon inhibits airway hyperreactivity and lung inflammation in a murine model of acute lung injury
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
HMGB1 is upregulated in ASM in asthma and induces ASM contraction via TLR4
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion
Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018
Year: 2018
Relaxation of tracheal smooth muscle is impaired in innate airway hyperresponsiveness
Source: Eur Respir J 2009; 33: 417-424
Year: 2009
Contractility of bronchial smooth muscle and changes during disease
Source: Annual Congress 2005 - Role of the bronchial smooth muscle in regulating airway disease
Year: 2005
Transcriptional regulation of CXCL8 hypersecretion in asthmatic airway smooth muscle cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Basic mechanisms of development of airway structural changes in asthma
Source: Eur Respir J 2007; 29: 379-389
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept